Mr. David Thompson

• 
  www.ispor.org/news/articles/Dec07/EUCP.asp - [Cached Version]
  Published on: 1/17/2008    Last Visited: 1/17/2008  

  Dave Thompson enjoying a pint.ISPOR CONNETIONS Associate Editor-in-Chief

• 
  www.i3innovus.com/en/bio_dthompson.php - [Cached Version]
  Published on: 8/3/2007    Last Visited: 8/3/2007  

  David Thompson, Ph.D.
  ...
  Dr. Thompson is responsible for scientific leadership and global direction of health economics and outcomes research with a concentration in decision analytic modeling.He joined Innovus (now i3 Innovus) in 2000 to lead the U.S. expansion.Dr. Thompson began his career in health economic consulting in 1988 and has since conducted hundreds of pharmacoeconomic analyses and outcomes research studies on new pharmaceutical, biotechnology, and medical device products.Although best known for his work in the economics of obesity, Dr. Thompson has experience in a wide range of therapeutic areas including diseases and disorders of the cardiovascular, respiratory, gastrointestinal, musculoskeletal, and central nervous systems as well as pediatric infectious diseases, sexually transmitted diseases, traumatic injuries, and others.He has co-authored a number of studies that have appeared in medical literature including articles in Journal of the American Medical Association, Archives of Internal Medicine, American Journal of Public Health, American Journal of Psychiatry, American Journal of Managed Care, Obesity Research, and American Journal of Health Promotion, among others.Dr. Thompson received a bachelor of science degree in economics from the University of California, Riverside and a doctorate degree in economics from the University of Massachusetts at Amherst.

• 
  : News @ PharmiWeb - [Cached Version]
  Published on: 6/3/2001    Last Visited: 9/11/2002  

  "In the US, three out of five adults are at least overweight and the number that is in the obese range is about 20% to 30%," said David Thompson, of Innovus Research Inc, a private health institute in Boston.
  
  "That prevalence of obesity is far higher than other advanced countries and that is why the economic burden of obesity is so much higher as well."
  
  In a review of the evidence to date on the economic burden of obesity, Dr. Thompson and his colleagues found that in France and Australia only 2% of healthcare costs were due to obesity, compared with 2.4% in Canada, 3.5% in Portugal and 2.5% in New Zealand.
  
  Figures were not available for other nations.In most European countries the obesity levels range from 10% to 20%.
  
  "It is fair to say that to the extent that other countries are going to follow in the footsteps of the US population the economic burden of obesity will increase in those countries as well," Thompson, a health economist, said.
  
  The analysis covered the costs of obesity-related disease, but did not include the treatment of obesity itself.The diet and fitness industry in the US alone accounts for some $30 billion annually, according to Thompson.
  
  Treating heart disease in the US costs an estimated $50 billion, similar to the amount spent on diabetes.Hypertension treatments account for some $15 billion and stroke $18 billion.
  
  "The most recent estimate of the burden of obesity is $70 million.Obesity is higher than all of these big ticket items because three out of five adults are obese, but three out of five don't have coronary heart disease," Thompson explained.
  
  "It is a prevalence issue as well as the fact that obesity is a risk factor for so many different diseases," he added.
  
  More than 300 million people around the globe are obese.About 115 million live in developed countries where high-fat diets and lack of exercise have led to rising levels of overweight and obese people.
  
  More than 2,500 doctors, researchers and health officials are attending the 4-day conference that began on Wednesday.
  
  © 2001 Reuters Limited.

• 
  A Call for Action - [Cached Version]
  Published on: 8/23/2001    Last Visited: 3/6/2005  

  (1) Dr. David Thompson, Innovus Research Inc.

• 
  American Society of Bariatric Physicians (ASBP) -... - [Cached Version]
  Published on: 7/24/2001    Last Visited: 12/27/2003  

  "Compared to individuals who are not overweight, individuals who are obese have elevated risks of heart disease and can expect to incur higher medical-care costs as a result," says the study's lead author David Thompson, PhD, senior economist, Policy Analysis, Inc., Brookline, Mass.
  ...
  "Our findings indicate that obesity imposes a significant health and economic burden on individuals who are obese," says Thompson."Clearly, efforts to reduce the prevalence of obesity can have important benefits in terms of reduction in the risks and costs of coronary heart disease."
  
  The American Heart Association recently designated obesity as a major modifiable risk factor for heart disease.While health-care expenditures in the U.S. attributable to obesity have been estimated to total over $50 billion, this is the first study that pinpoints the expected lifetime costs of obesity from the perspective of an individual person, says Thompson.The study also reported that individuals who are obese are likely to live a greater portion of their lives with heart disease.The expected number of years of life with heart disease increased from 2.7 among men, age 45 to 54, who are not obese, to 3.1 for those mildly obese, 3.7 for those moderately obese, and 4.5 years for those severely obese.Expected years with heart disease for women of the same age ranged from 2.2 for those of normal weight to 3.7 for the severely obese.
  
  The study was based on data from the Framingham Heart Study and the Third National Health and Nutrition Examination Survey.Thompson says he and his colleagues conducted the study to increase awareness of the health and economic consequences of excess body weight."The problem of obesity is reaching epidemic proportions," he says.

• 
  As omnibus completion draws near, lobbyists face... - [Cached Version]
  Published on: 1/29/2003    Last Visited: 1/29/2003  

  David Thompson, Capitol Hill Group (former aide to Speaker)

• 
  Boards of Directors Take Action in 2007 - [Cached Version]
  Published on: 1/1/2007    Last Visited: 3/28/2008  

  • The Board approved Thomas Mittendorf PhD, MSc, Universität Hannover, Hannover, Germany and David Thompson PhD, Vice President, Global Health Economics, Medford, MA, USA as 2008-2012 Co-Editors-in-Chief for ISPOR CONNECTIONS.

• 
  CRT -- Is There Really a Human Organ Shortage? -... - [Cached Version]
  Published on: 2/3/2006    Last Visited: 8/16/2009  

  Gerry Oster, PhD, David Thompson, PhD, "Estimated Effects of Reducing Dietary Saturated Fat Intake on the Incidence and Costs of Coronary Heart Disease in the United States," Journal of the American Dietetic Association , Vol.
  ...
  Gerry Oster is Vice President and David Thompson is Senior Economist at Policy Analysis Inc., Brookline, MA.

• 
  Capitol Hill Consulting Group - David Thompson - [Cached Version]
  Published on: 11/7/2009    Last Visited: 11/7/2009  

  David Thompson serves as Senior Vice President of Capitol Hill Consulting Group, where he represents clients on issues related to appropriations, energy, health care, high-technology, and financial services.
  
  Prior to joining Capitol Hill Consulting Group, Mr. Thompson served as a longtime aide to U.S. House Speaker J. Dennis Hastert (R-IL), where he started working in 1993.
  
  After serving many years in the personal office staffing the Congressman on the powerful Energy and Commerce Committee, Mr. Thompson moved to the Speaker's policy office. He most recently served as Assistant to the Speaker for Policy, focusing on Agriculture, Energy, Environment, Judiciary, and Natural Resource issues.
  
  Mr. Thompson holds a Bachelors Degree in Political Science from Taylor University in Upland, Indiana. The Taylor University Alumni Association named him the "2001 Distinguished Young Alumnus."
  
  Mr. Thompson resides in Arlington, Virginia, with his wife and their four children.
  
  David Thompson

• 
  Coronary Heart Disease - [Cached Version]
  Published on: 1/22/2001    Last Visited: 11/3/2002  

  "For years, public and private health and medical organizations have recommended that American follow a low-fat, low-calorie diet as part of a healthful lifestyle," said David Thompson, Ph.D., senior economist at Policy Analysis, Inc., Brookline, Mass., and co-author of the JADA study."But the nutrition community and policy makers have had a difficult time translating the health benefits of low-fat eating into economic benefits for individuals, insurers, and society as a whole."
  
  The study determined CHD risk for population subgroups defined according to age, gender, and cholesterol levels.It also reviewed estimates of annual medical care expenditures and earnings losses associated with alternative manifestations of CHD, such as sudden death and myocardial infarction.The study used existing scientific data on benefits of cholesterol reduction and updated earlier disease costs estimates from 1980 to 1993 levels, using the medical care component of the Consumer Price Index.
  
  ...
  "Our cost-savings figures probably underestimate the full economic benefits of reducing dietary fat intake," said Thompson."Our figures relate only to adults who are currently disease free, and we focused attention on coronary heart disease--even though reducing fat intake has been linked to reductions in the incidence of certain cancers as well."

Page:  1 2 3